NAD+ Biology: Why It Declines 40–50% With Age, How CD38 Drives That Decline, and Whether NMN, NR, or Niacin Can Actually Restore It

NAD+ Functions: Why This Molecule Is So Biologically Important

NAD+ functions in two distinct capacities that are often conflated:

As a Redox Coenzyme

NAD+ and its reduced form NADH are essential electron carriers in cellular energy metabolism. In glycolysis, the citric acid cycle, and oxidative phosphorylation, NAD+ accepts electrons from metabolic intermediates to become NADH, which then donates electrons to the electron transport chain (Complex I) to produce ATP. Without adequate NAD+, these pathways stall. This is the classical biochemistry textbook role — NAD+ as a coenzyme that is recycled, not consumed.

As a Substrate for Signaling Enzymes

More recently recognized is NAD+'s role as a consumed substrate for a class of enzymes that use it non-catalytically — breaking the glycosidic bond to release nicotinamide and use the ADP-ribose moiety for cellular signaling. The primary consumers:

• Sirtuins (SIRT1–7): NAD+-dependent deacetylases (and deacylases) that remove acetyl groups from lysine residues on histones and metabolic enzymes. Each deacetylation reaction consumes one NAD+ molecule. SIRT1 activates PGC-1α (mitochondrial biogenesis), regulates FOXO3a (oxidative stress resistance), and deacetylates p53. SIRT3 maintains mitochondrial function. SIRT6 repairs DNA double-strand breaks. The sirtuin "alarm system" model: sirtuins respond to elevated NAD+ (metabolic stress, caloric restriction) as a signal to upregulate survival/repair programs.
• PARP1 (Poly-ADP-Ribose Polymerase 1): Detects and repairs DNA single-strand breaks by consuming NAD+ to synthesize poly-ADP-ribose chains that recruit repair machinery. Under high DNA damage burden (aging, oxidative stress), PARP1 hyperactivation can consume so much NAD+ that it starves sirtuins — creating a vicious cycle between DNA damage, NAD+ depletion, and impaired sirtuin-mediated repair. This is the "PARP1–Sirtuin competition" model central to NAD+ aging theories.
• CD38: An NAD+ase and ADP-ribose cyclase expressed on immune cells and other tissues. Unlike PARP1 which responds to DNA damage, CD38 constitutively hydrolyzes NAD+ with very high efficiency. CD38 levels increase dramatically with age and with inflammatory signaling — connecting inflammaging directly to NAD+ decline. Camacho-Pereira et al. 2016 showed CD38-KO mice have 2–3× higher NAD+ than wild-type at the same age and are protected from diet-induced metabolic syndrome.

The NAD+ Biosynthesis Pathways

NAD+ can be synthesized via three converging routes:

1. De novo from tryptophan (Preiss-Handler pathway): Tryptophan → kynurenine → quinolinate → NaMN → NaAD → NAD+. This is the only truly "from scratch" synthesis route but is metabolically expensive and cannot keep pace with age-related increased consumption.
2. Salvage pathway from nicotinamide (NAM): The primary route in most tissues. Nicotinamide (NAM, released when sirtuins and PARPs consume NAD+) is recycled back to NMN by NAMPT (nicotinamide phosphoribosyltransferase), then to NAD+ by NMNAT enzymes. NAMPT is the rate-limiting enzyme in this pathway — and NAMPT expression declines with age, reducing salvage efficiency. NMN supplementation bypasses this bottleneck by providing NMN directly.
3. From NR or niacin (nicotinic acid): NR (nicotinamide riboside) is phosphorylated to NMN by NRK1/2 (NR kinases), then proceeds through NMNAT to NAD+. Niacin (nicotinic acid) enters via the Preiss-Handler route through NAPRT.

The key insight: both NMN and NR bypass NAMPT (the declining rate-limiting enzyme) by entering the salvage pathway downstream. This is why they are more effective at raising NAD+ than simply supplementing nicotinamide, which still requires NAMPT to convert it to NMN.

Human Trial Evidence for NAD+ Precursors